ghk-cu fda approved status approval injectable GHK-Cu Side Effects: What Does the Research Say? Doctor Explains GHK-Cu (Copper Peptide) for Lab
Description
At minimum: Outcomes Weight trend (weekly average) Waist circumference Body composition if available (DEXA, BIA with consistency) Strength markers (basic lifts, grip strength, functional tests) Safety Blood pressure + resting HR A1c and fasting glucose (more often if diabetes) CMP (liver/kidney) Lipids (periodic) If manipulating GH/IGF-1 signaling: IGF-1 (and clinical context matters) Stop criteria Persistent tachycardia, edema, severe fatigue, worsening glycemia, abnormal labs, or new symptoms you cant explain The what to ask your clinic questions (high signal, low fluff) If a clinic recommends a peptide stack, ask: What is the problem were solving, in one sentence

Neuroprotection: Emerging research suggests that BPC-157 may possess neuroprotective properties, potentially offering benefits in the treatment of neurological conditions such as stroke and traumatic brain injury [8]

Those taking tirzepatide (as opposed to a placebo) were far less likely to develop type 2 diabetes

Chai, J.-D
